|
Market Closed -
Toronto S.E.
14:37:33 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 19.64 CAD | +0.26% |
|
+2.08% | -7.84% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-10 | Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says | MT |
| Market Cap | 90.36B 104B 84.72B 77.17B 145B 9,927B 147B 997B 389B 4,984B 391B 382B 16,603B | P/E 2026 * |
12x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 95.42B 86.92B 163B 11,181B 166B 1,123B 438B 5,614B 440B 431B 18,701B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.95x |
| Free-Float |
88.34% | Yield 2026 * |
5.64% | Yield 2027 * | 5.96% |
Last Transcript: Sanofi
| 1 day | +0.26% | ||
| 1 week | +2.08% | ||
| Current month | +3.86% | ||
| 1 month | -0.41% | ||
| 3 months | +3.59% | ||
| 6 months | -8.31% | ||
| Current year | -7.84% |
| 1 week | 19.27 |  | 19.66 |
| 1 month | 18.91 | | 21.19 |
| Current year | 18.8 | | 22.02 |
| 1 year | 18.8 | | 22.57 |
| 3 years | 18.8 | | 22.57 |
| 5 years | 18.8 | | 22.57 |
| 10 years | 18.8 | | 22.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.26% | +2.08% | - | - | 104B | |
| +0.43% | +9.38% | +92.10% | +130.99% | 1,083B | |
| +0.41% | +2.33% | +50.07% | +50.05% | 626B | |
| -0.53% | +2.03% | +25.23% | +63.46% | 442B | |
| -0.92% | +2.18% | +48.40% | +37.85% | 363B | |
| -1.32% | -0.32% | +29.35% | +36.81% | 295B | |
| -1.20% | -0.32% | +6.03% | +6.09% | 248B | |
| +0.45% | +6.71% | +45.98% | +58.54% | 224B | |
| -2.51% | -2.63% | -7.16% | -51.74% | 210B | |
| +0.07% | +0.46% | +12.78% | +69.84% | 168B | |
| Average | -0.52% | +2.88% | +33.64% | +44.65% | 406.57B | |
| Weighted average by Cap. | -0.36% | +4.29% | +49.44% | +65.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.51B 54.75B 44.54B 40.57B 76.31B 5,219B 77.54B 524B 204B 2,620B 206B 201B 8,729B | 50.61B 58.32B 47.45B 43.22B 81.3B 5,560B 82.61B 559B 218B 2,792B 219B 214B 9,299B |
| Net income | 7.94B 9.15B 7.45B 6.78B 12.76B 872B 12.96B 87.66B 34.16B 438B 34.36B 33.6B 1,459B | 9.27B 10.68B 8.69B 7.91B 14.89B 1,018B 15.13B 102B 39.86B 511B 40.09B 39.21B 1,703B |
| Net Debt | 11.42B 13.16B 10.7B 9.75B 18.34B 1,254B 18.63B 126B 49.1B 630B 49.39B 48.3B 2,098B | 8.23B 9.49B 7.72B 7.03B 13.22B 904B 13.44B 90.88B 35.41B 454B 35.62B 34.84B 1,513B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | $19.64 | +0.26% | 100 |
| 26-08-11 | $19.59 | +0.15% | 408 |
| 26-08-10 | $19.56 | +0.51% | 1,908 |
| 26-08-07 | $19.46 | +0.62% | 2,350 |
| 26-08-06 | $19.34 | +0.52% | 3,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNY Stock
Select your edition
All financial news and data tailored to specific country editions
